Home › Melanoma › Pennsylvania › Philadelphia
Pag-aaral pangklinika para sa Melanoma sa Philadelphia, PA
Isang pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Philadelphia. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mi ang layo
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Nagre-recruitPhase 3
- Fox Chase Cancer Center, Philadelphia
DESTINY-PANTUMOUR04
Nagre-recruitObservasyonal na pag-aaral
- Research Site, Philadelphia
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Nagre-recruitPhase 2
- Thomas Jefferson University Hospital, Philadelphia
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Nagre-recruitPhase 2
- Children's Hospital of Philadelphia, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · 25 mi ang layo
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Nagre-recruitPhase 3
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi ang layo
- at 3 pa
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Nagre-recruitPhase 1/2
- University of Pennsylvania, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Nagre-recruitObservasyonal na pag-aaral
- University of Pennsylvania, Philadelphia
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Drexel University School of Medicine, Philadelphia
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- at 1 pa
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Nagre-recruitPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
Tebentafusp-tebn With LDT in Metastatic UM
Nagre-recruitPhase 1/2
- Thomas Jefferson University, Philadelphia
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
Nagre-recruitPhase 1/2
- Fox Chase Cancer Center, Philadelphia
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Nagre-recruitPhase 1/2
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
Nagre-recruitMaagang Phase 1
- Fox Chase Cancer Center, Philadelphia
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Nagre-recruitPhase 1/2
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Nagre-recruitPhase 3
- Jefferson Health Honickman Center, Philadelphia
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Nagre-recruitPhase 2/3
- UPenn, Philadelphia
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Nagre-recruitPhase 2/3
- Thomas Jefferson University, Philadelphia
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Nagre-recruitPhase 3
- Thomas Jefferson University Medical Oncology Clinic, Philadelphia
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Nagre-recruitPhase 3
- Fox Chase Cancer Center 333 Cottman Avenue, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Philadelphia
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
Nagre-recruit
- University of Pennsylvania, Philadelphia
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Nagre-recruit
- Fox Chase Cancer Center, Philadelphia
Pag-aaral para sa Melanoma sa ibang lungsod
- Houston, TX59 pag-aaral
- New York City, NY38 pag-aaral
- Los Angeles, CA34 pag-aaral
- Nashville, TN33 pag-aaral
- Pittsburgh, PA31 pag-aaral
- Boston, MA26 pag-aaral
- San Francisco, CA22 pag-aaral
- Columbus, OH21 pag-aaral
- St. Louis, MO21 pag-aaral
- Atlanta, GA21 pag-aaral
- Durham, NC21 pag-aaral
- Salt Lake City, UT21 pag-aaral
Iba pang pag-aaral sa Philadelphia
- Kanser (lahat ng uri)59 pag-aaral
- Kanser sa Suso56 pag-aaral
- Non-Small Cell Lung Cancer51 pag-aaral
- Metastatic Cancer46 pag-aaral
- Kanser sa Prostate44 pag-aaral
- Colorectal Cancer44 pag-aaral
- Kanser sa Ovary44 pag-aaral
- Kanser sa Baga36 pag-aaral
- Acute Myeloid Leukemia34 pag-aaral
- Pagkabigo ng Puso31 pag-aaral
- Kanser ng Endometrium28 pag-aaral
- Depression26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.